web analytics
14.6 C
Munich
Sunday, September 25, 2022

South Beach Spirits Inc (OTCMKTS: SBES) the Soleil Pharma Revere Merger

South Beach Spirits Inc (OTCMKTS: SBES) is rocketing up the charts from its $0.004 base and 52-week lows as Mr. Suren Ajjarapu takes over the Company and files with the Delaware State secretary to rename the Company Soleil Pharma and move it to Delaware.  Suren Ajjarapu is CEO of Ocean Biomedical OCEA and Nasdaq listed Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) currently at $10 per share. Sandhya Ajjarapu has been installed as CEO and Annapurna Gundlapalli as president while Suren Ajjarapu sits on the bod. 

Reverse merger SPACS can be more explosive than biotech’s when the incoming Company has real value but is undiscovered to investors and many RM stocks we have covered on this website have gone from pennies to dollars. Mr. Suren Ajjarapu is an entrepreneur with leadership experience, extensive executive management and corporate board experience. Mr. Ajjarapu is an accomplished corporate strategist, fund raiser and marketer. His vision and expertise in business performance have driven notable enterprise growth in the Biofuels and Information Technology sectors. Offering a rare blend of creative and operational strengths, Mr. Ajjarapu has demonstrated the capability to deal with cross-cultural, socio-economic, and geo-political boundaries as well as to expand or launch new businesses on a global basis with a keen sense of time to market. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

South Beach Spirits Inc (OTCMKTS: SBES) operating out of Richmond Hill, Ontario is clean shell with no debt, “pink current” and a perfect merger candidate. South Beach Spirits was incorporated in the State of Nevada on August 10, 2012 under the name “CME REALTY, INC.” and its year-end is February 28. The Company’s initial plan of operations was to engage in providing real estate services for the Las Vegas residential market. The Company was unable to implement this plan of operations for a number of reasons, including without limitation, the inability to raise sufficient capital. In September, 2015 the Company changed its name from CME Realty, Inc. to South Beach Spirits Inc (SBES) 

To Find out the inside Scoop on SBES Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

SBES

SBES was uner the control of Caren Currier who has been making name for herself in the world of SPACS “The REVERSE MERGER specialist” since we last reported on the Company.(See IGEX, ILUS, AXTG, SSOF just to name a few of Caren Currier recent SPACS). Caren Currier has earned an incredible reputation in the OTC as a merger GURU. As the current CFO for the investment holding Company FCCC, Inc. and One World Universal, Currier has the experience and know-how to reliably get shell companies up to speed.  “Pink Current” SBES has momentum, huge liquidity and legions of new shareholders bidding up the price.    

 

For more on SBES Subscribe Right Now!

SBES is making a powerful run northbound in recent trading on significant volume trading billions of shares and emerging as a top traded stock in small caps. SBES is getting noticed by some big players as it rockets up the charts from its $0.004 base and 52-week lows as Mr. Suren Ajjarapu takes over the Company and files with the Delaware State secretary to rename the Company Soleil Pharma and move it to Delaware.  Suren Ajjarapu is CEO of Ocean Biomedical OCEA and Nasdaq listed Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) currently at $10 per share. Reverse merger SPACS can be more explosive than biotech’s when the incoming Company has real value but is undiscovered to investors. We will be updating on SBES so make sure you Subscribe to Microcapdaily so you know what’s going on with SBES.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in SBES either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.